Source: investors.poseida.com

Followers on Owler

1,118

Annual Revenue

$100-500M

Employees

250-500

President & CEO

Kristin Yarema

CEO Approval Rating

85/100

Poseida is a California-based biopharmaceutical company that researches and develops gene therapies for the treatment of cancer and genetic diseases.

Poseida Was acquired by F. Hoffmann-La Roche Ltd. for $1.5B